Motexafin Gadolinium, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
Clinical trial NCT00305864 · COMPLETED
Trial details
- NCT number
- NCT00305864
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-02-09
- Primary completion
- 2011-02-16
- Enrollment
- 118
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.